MedPath

Offering HPV Self-Collection in Novel Healthcare Settings to Improve Uptake of Cervical Cancer Screening

Not Applicable
Not yet recruiting
Conditions
Cervical Carcinoma
Human Papillomavirus Infection
Human Papillomavirus-Related Cervical Carcinoma
Registration Number
NCT07186530
Lead Sponsor
Mayo Clinic
Brief Summary

This clinical trial evaluates whether offering human papillomavirus (HPV) self-collection for cervical cancer screening at Mayo Clinic Express Care clinics improves uptake of cervical cancer screening and receipt of appropriate follow-up care. Cervical cancer is preventable through vaccination, screening, and treatment of pre-cancerous conditions. Despite this, the rates of outdated cervical cancer screening tests are high. Usual care at Mayo Clinic currently includes annual portal or letter communications in the form of scheduled outreach to request scheduling an appointment for cervical cancer screening, as well as reminders from clinicians during clinic appointments. Cervical cancer screening at Mayo Clinic is most often done with a pelvic speculum exam with cervical swabs collected in the office by a clinician. HPV self-collection is Food and Drug Administration-approved and already used in clinical practice, but offering this method of screening in the novel setting of Express Care clinics that have expanded nighttime and weekend hours may improve rates of cervical cancer screening and receipt of appropriate follow-up care.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
500
Inclusion Criteria
  • Women ages 30-63 years old receiving primary care with a provider at Mayo Clinic in Rochester or Mayo Family Clinic Kasson and who self-identify as asymptomatic (i.e., no pelvic pain, abnormal vaginal bleeding or abnormal vaginal discharge)
  • Qualify for average risk cervical cancer screening per United States Preventive Services Task Force (USPSTF) guidelines but are overdue by >= 1 year, including those who have never been screened
  • Must have an active Patient Online Services account (patient portal), approval for research contact status in portal/Epic and documentation of Minnesota (MN) research authorization, and health insurance coverage
Exclusion Criteria
  • History of hysterectomy
  • Cervical cancer
  • Cervical intraepithelial neoplasia (CIN) 2-3
  • In utero diethylstilbestrol (DES) exposure
  • HIV+
  • Use of chronic immunosuppressant medication
  • Known to be pregnant
  • Medicare-covered women are NOT eligible as Medicare does not cover primary HPV testing by clinician-collection or self-collection [related to outdated Centers for Medicare & Medicaid Services (CMS) cervical cancer screening coverage rules for Medicare that date back to 2015, 3 years before primary HPV screening was endorsed by USPSTF]

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Cervical cancer screening testUp to 6 months from trial enrollment

Assessed by the number of participants who complete cervical cancer screening collection from invitation to complete a self-collected vaginal swab for HPV testing at Mayo Clinic Express Care clinics compared to the number of participants who complete screening with a clinician-collected cervical swab or self-collected vaginal swab at a primary care office.

Secondary Outcome Measures
NameTimeMethod
Follow-up of abnormal resultsUp to 6 months from date of test

Assessed by the number of participants who complete follow-up for abnormal results obtained by self-collection or clinician-collection.

Trial Locations

Locations (2)

Mayo Family Clinic Kasson

🇺🇸

Kasson, Minnesota, United States

Mayo Clinic in Rochester

🇺🇸

Rochester, Minnesota, United States

Mayo Family Clinic Kasson
🇺🇸Kasson, Minnesota, United States
Julie Maxson
Contact
507-266-0284
maxson.julie@mayo.edu
Kathy L. MacLaughlin, PhD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.